BXP — Beximco Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £240.90m
- £253.42m
- BDT49.12bn
Beximco Pharmaceut - Financial Results for the First Quarter
Brief: Beximco Pharmaceuticals Says FY Profit After Tax Down 3.2%
Beximco Pharmaceut - Results for the 12-month period ended 30 June 2022
Beximco Pharmaceut - Notification of Preliminary Results and AGM
Brief: Beximco Pharmaceuticals Net Revenue £229.1M For 9 Months Ended 31 March
Beximco Pharmaceut - Q3 Financial Results
Beximco Pharmaceut - Sanofi Bangladesh Ltd. renamed Synovia Pharma PLC
Brief: Beximco Pharmaceuticals Says MPP Granted Sub-License For Pfizer's COVID-19 Treatment
Beximco Pharmaceut - MPP sub-license for Pfizer’s COVID-19 treatment
Brief: Beximco Pharmaceuticals HY Net Sales Increased 17.8% To Bangladesh Taka 16,968.9M
Beximco Pharmaceut - Half Year Results 2021-22
Beximco Pharmaceut - Payment of Cash Dividend
Brief: Beximco Pharmaceuticals Says Granted License To Produce Molnupiravir For COVID-19
Beximco Pharmaceut - License to produce molnupiravir for COVID-19
Brief: Beximco Pharmaceuticals Ltd Introduces World's First Generic Version Of Pfizer's Paxlovid
Beximco Pharmaceut - World's first generic version of Pfizer’s Paxlovid
Beximco Pharmaceut - Annual General Meeting Statement
Brief: Beximco Receives Delivery Of 2.5 Mln Covid-19 Vaccine Doses From SII
Beximco Pharmaceut - Delivery of COVID-19 vaccine doses